The global Automated External Defibrillators market size is expected to grow at US$ 49.6 billion in 2027 at a compound annual growth rate (CAGR) of 11.5%.
Automated external defibrillators (AEDs) are medical equipment that diagnose sudden ventricular fibrillation, cardiac arrhythmia, cardiac arrest, or pulseless ventricular tachycardia in order to deliver an electric shock. Heart failure and organ perfusion issues are caused by pulseless ventricular tachycardia, a cardiac arrhythmia in which coordinated ventricular contractions are replaced with extremely quick but ineffective contractions. When used in conjunction with cardiopulmonary resuscitation (CPR), AEDs can boost the victim's chance of survival. CPR is a procedure that combines chest compressions and rescue breathing. It is utilized to provide the brain with sufficient blood flow until specialized treatment is available. The American Heart Association claims that providing CPR and utilizing an AED almost doubles the patients' chances of survival. While CPR helps to maintain blood flow, AED helps to maintain a heart rhythm. The primary factors driving market expansion are technological advancements in automated defibrillators, an increase in the prevalence of cardiovascular illnesses, and growing population ageing. Additionally, the market is growing due to the increased focus on providing public access defibrillators. On the other hand, greater pricing pressure on market players stifles market expansion.
09-Apr-2019: Stryker Launches LIFEPAK® CR2 Defibrillator with LIFELINKcentral™ AED Program Manager in the United States --
Stryker has launched the company’s newest defibrillation solution, the LIFEPAK® CR2 defibrillator with LIFELINKcentral™ AED program manager, in the United States. The company has announced that the LIFEPAK CR2 automated external defibrillator (AED) has received Premarket Approval (PMA) by FDA. The LIFPAK CR2 AED was previously released in Europe and Canada in 2017, and in Japan in 2018.
Market is segmented based on the type, applications, companies and regions.
By Type, it is segmented into
By Application, it is segmented into
North America is the largest region in the market and is predicted to develop at a CAGR of 9.32% by 2030. The US is the primary driver of regional expansion. Due to the frequency of cardiovascular disorders, the introduction of new products, and the presence of major market participants in the US, the market for automated external defibrillators is expanding. Nearly half of all Americans, according to data from the American Heart Association released in January 2019, have a cardiovascular condition, such as hypertension or coronary heart disease, which is predicted to increase the number of cardiovascular patients in the nation and fuel market expansion. Europe is predicted to earn USD 603 million in sales by 2030, with a CAGR of 9.70%. The expanding European AED market is anticipated to receive the majority of its support from Germany and France. The high prevalence of cardiovascular disorders in Germany is the key factor driving the market for automated external defibrillators, together with the introduction of new devices and the country's extensive infrastructure for research and development (AEDs).
The Automated External Defibrillators Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Automated External Defibrillators Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
Report Attributes | Report Details |
Forecast Period 2022 to 2027 CAGR | CAGR of 11.5% over the forecast period (2022-2027) |
By Type |
|
By Application |
|
By Companies | Abbott, Boston Scientific, Zoll Medical Corporation (Asahi Kasei), Biotronik, Physio-Control International, Cardiac Science Corporation (Aurora Capital), Sorin Group (Livanova), Nihon Kohden, Medtronic PLC, St. Jude Medical Inc., Schiller AG, Stryker Corporation, Mediana Co. Ltd, ZOLL Medical Corporation, Cardiac Science Corporation, Koninklijke Philips, ViVest Medical |
Regions Covered |
|
Countries Covered |
|
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2022 to 2027 |
Number of Pages | 132 |
Customization Available | Yes, the report can be customized as per your needs |
What is the growth rate of Automated External Defibrillators Market?
The Automated External Defibrillators Market is growing at a CAGR of 11.5% over the next 5 years.
Who are the key players in Automated External Defibrillators Market?
Abbott, Boston Scientific, Zoll Medical Corporation (Asahi Kasei), Biotronik, Physio-Control International, Cardiac Science Corporation (Aurora Capital), Sorin Group (Livanova), Nihon Kohden, Medtronic PLC, St. Jude Medical Inc., Schiller AG, Stryker Corporation, Mediana Co. Ltd, ZOLL Medical Corporation, Cardiac Science Corporation, Koninklijke Philips, ViVest Medical
What are the significant types of Automated External Defibrillators Market?
Semi-Automated External Defibrillators, Fully Automated External Defibrillator
What are the major end-use applications of Automated External Defibrillators Market?
Hospitals, Clinics, & Cardiac Centers, Pre-Hospitals, Public Access, Home Care, Alternate Care
All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.